Connecting Scientific Expertise with Innovation, Preparedness & National Priorities

CA Analytical Testing Services is proud to participate in leading industry and government-supported consortia advancing pharmaceutical development, biomanufacturing, medical technology, biodefense, and chemical, biological, radiological, and nuclear (CBRN) preparedness.

Through these memberships, CA Analytical is part of a broader community of pharmaceutical and biotechnology companies, technology developers, research institutions, government partners, and other organizations working to advance technologies that protect public health and strengthen national preparedness.

Our participation also creates opportunities to contribute our analytical testing, method development, characterization, and laboratory expertise to collaborative research and development initiatives.

Countering Weapons of Mass Destruction Consortium (CWMD)

The Countering Weapons of Mass Destruction Consortium brings together industry, academia, nonprofit organizations, traditional government contractors, and nontraditional technology providers to support the development of technologies addressing chemical, biological, radiological, and nuclear threats.

The consortium works with U.S. Government partners through an Other Transaction Agreement (OTA) framework designed to accelerate research, development, prototyping, and deployment of innovative technologies.

CA Analytical’s membership reflects our interest in supporting the analytical and scientific requirements associated with emerging technologies for detection, protection, prevention, and CBRN defense.

[Visit the CWMD Consortium →]

Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium)

The Biopharmaceutical Manufacturing Preparedness Consortium, established by the Biomedical Advanced Research and Development Authority (BARDA), connects organizations throughout the U.S. biopharmaceutical manufacturing ecosystem.

Its members include pharmaceutical and biotechnology manufacturers, raw-material and consumable suppliers, technology developers, research organizations, and service providers working to strengthen domestic manufacturing capabilities and improve preparedness for future public health emergencies.

As a BioMaP-Consortium member, CA Analytical brings analytical testing and pharmaceutical development capabilities to an ecosystem focused on strengthening U.S. biopharmaceutical manufacturing and public health preparedness.

[Visit the BioMaP-Consortium →]

Medical Technology Enterprise Consortium (MTEC)

The Medical Technology Enterprise Consortium accelerates the development of medical technologies that improve the health and performance of military personnel and civilians.

MTEC brings together businesses, academic institutions, healthcare organizations, investors, and government agencies to advance technologies including pharmaceuticals, biologics, diagnostics, medical devices, digital health technologies, and other medical innovations.

CA Analytical’s membership expands our ability to engage with organizations developing next-generation medical technologies that may require specialized analytical testing, method development, product characterization, and regulatory-support services.

[Visit MTEC →]

Medical CBRN Defense Consortium (MCDC)

The Medical CBRN Defense Consortium is focused specifically on accelerating the development of medical countermeasures for chemical, biological, radiological, and nuclear threats.

Working with U.S. Department of Defense partners through an OTA framework, MCDC supports the advancement of technologies for CBRN prevention, diagnosis, and treatment, including pharmaceuticals, biologics, vaccines, diagnostics, therapeutics, and enabling technologies.

CA Analytical’s participation in MCDC aligns our pharmaceutical and analytical expertise with organizations developing medical solutions for some of the most complex challenges in CBRN defense and emergency preparedness.

[Visit the Medical CBRN Defense Consortium →]

Supporting Innovation Through Analytical Science

Innovative pharmaceutical, biotechnology, defense, and medical-countermeasure programs often present analytical challenges that cannot be addressed with a one-size-fits-all testing approach.

CA Analytical Testing Services provides scientific and laboratory support across areas including:

Analytical method development and validation
Pharmaceutical and biopharmaceutical testing
R&D analytical support
Extractables and leachables studies
Impurity and unknown identification
LC-MS and GC-MS analysis
HPLC and UHPLC testing
ICP-MS and elemental analysis
Stability and quality-control testing
Materials and product characterization
Customized analytical studies for complex or novel products

Our consortium memberships help connect these capabilities with organizations advancing new technologies across pharmaceutical development, public health preparedness, medical technology, and national defense.

Looking for an Analytical Development Partner?

Whether you are developing a pharmaceutical product, medical countermeasure, diagnostic technology, novel material, or other emerging technology, our scientists can help develop an analytical strategy tailored to your program.

Talk to a Scientist | Request a Quote